Validation of the role of corrected DLCO in predicting outcomes post autologous hematopoietic cell transplant for multiple myeloma

Eur J Haematol. 2023 Jun;110(6):780-783. doi: 10.1111/ejh.13961. Epub 2023 Mar 30.

¹ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, 44195, USA.
² Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, 44195, USA.
³ Department of Internal Medicine, Cleveland Clinic Akron General, Akron, Ohio, 44307, USA.
⁴ Multiple Myeloma Program, Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, 44195, USA.

No abstract available

Publication types